Claims Data and Administrative Data in Medical Device Marketing

Understanding Claims Data and Its Role in Medical Device Marketing

Every time a medical procedure is performed in the United States, it generates a trail of administrative records. Insurance claims, procedure codes, diagnosis codes, and billing records create a vast dataset that captures the clinical and financial reality of healthcare delivery. For medical device companies, this data represents one of the most underutilized marketing intelligence sources available.

Claims data and administrative data provide insights that no other data source can match. They reveal which procedures are being performed, where they are being performed, how often individual physicians perform specific procedures, what devices and implants are being used, and how reimbursement patterns are shifting across payers and geographies. When analyzed effectively, this data transforms medical device marketing from guesswork into precision targeting.

At Buzzbox Media, we work with medical device companies in Nashville and across the country to integrate claims data into their marketing and sales strategies. This guide explains what claims data is, where it comes from, how to access it, and how to use it to sharpen your marketing, improve sales targeting, and build a stronger competitive position.

What Is Claims Data?

Types of Claims Data

Claims data is generated every time a healthcare provider submits a bill to a payer for services rendered. There are several types of claims data relevant to medical device marketing. Professional claims (CMS-1500 forms) are submitted by individual physicians and include CPT procedure codes, ICD-10 diagnosis codes, the provider's NPI number, place of service, and charges. These claims tell you what procedures a specific physician performed and where.

Institutional claims (UB-04 forms) are submitted by hospitals and facilities and include revenue codes, procedure codes, diagnosis codes, and facility information. These claims provide a facility-level view of procedure volumes and case mix. Pharmacy claims track prescription drug dispensing and are less directly relevant to most device companies but can be useful for companies whose devices are used in conjunction with specific drug therapies.

Together, professional and institutional claims create a comprehensive picture of clinical activity across the healthcare system. When combined, they reveal the full patient journey from initial diagnosis through treatment, including which providers were involved at each step, which procedures were performed, and what was billed.

Administrative Data Beyond Claims

Administrative data extends beyond insurance claims to include hospital discharge records, vital statistics, public health surveillance data, and facility reporting data. The Healthcare Cost and Utilization Project (HCUP), maintained by the Agency for Healthcare Research and Quality (AHRQ), aggregates hospital discharge data from participating states and provides national estimates of procedure volumes, cost, and outcomes.

The Centers for Medicare and Medicaid Services (CMS) publishes extensive administrative datasets, including Medicare Provider Utilization and Payment Data, which shows how many times each procedure code was billed by each provider, and Inpatient Prospective Payment System (IPPS) data, which reveals hospital case volumes and reimbursement patterns. These public datasets are freely available and provide a foundation for market analysis that many medical device companies overlook.

Where Claims Data Comes From

Commercial Claims Databases

Several commercial data vendors aggregate claims data from multiple payers and make it available for analysis. IQVIA (formerly IMS Health and Quintiles) is the largest provider of healthcare data and analytics, with claims data covering a significant portion of the US commercially insured population. Symphony Health (now part of IQVIA) provides integrated claims data that connects physician, pharmacy, and hospital records.

Truven Health Analytics (now part of Merative, formerly IBM Watson Health) offers the MarketScan databases, which contain commercial claims data from large employers and health plans. Optum Clinformatics provides de-identified claims data from UnitedHealth Group's commercially insured population, one of the largest single-payer datasets in the country.

These commercial databases come at significant cost. Annual licenses can range from $50,000 to over $500,000 depending on the data scope, geographic coverage, and level of detail. For large medical device manufacturers, this investment is justified by the depth of market intelligence it provides. For smaller companies, public datasets and targeted data purchases may be more cost-effective starting points.

Public Data Sources

CMS publishes several free datasets that are valuable for medical device marketing. The Medicare Physician and Other Practitioner data file shows the number of services, average submitted charges, and average Medicare payment for each CPT code by provider and by geography. The Provider of Services file lists every Medicare-certified hospital and facility with details about bed count, ownership, and services offered.

The Medicare Inpatient dataset reveals DRG-level case volumes for every hospital that participates in Medicare. The Ambulatory Surgical Center (ASC) Payment data shows procedure volumes and payments for outpatient surgical procedures. The National Plan and Provider Enumeration System (NPPES) provides NPI-level data for every healthcare provider in the country.

State-level data sources supplement federal data. Many states maintain all-payer claims databases (APCDs) that include both commercial and public payer claims. As of 2024, approximately 20 states have operational APCDs, with more in development. These databases provide a more complete picture of procedure volumes than Medicare-only data, which is particularly important for procedures that skew toward younger, commercially insured populations.

Using Claims Data for Market Sizing and Opportunity Analysis

Procedure Volume Tracking

The most fundamental application of claims data in medical device marketing is tracking procedure volumes. By analyzing CPT code frequency over time, you can determine whether the procedures your devices support are growing, stable, or declining. This intelligence directly informs product development priorities, marketing investment decisions, and sales territory planning.

For example, a company that manufactures laparoscopic surgical instruments can track the volumes of specific laparoscopic procedure codes relative to their open surgery equivalents. If laparoscopic adoption is accelerating in certain geographies or specialties, that represents a growth opportunity. If a new minimally invasive approach is emerging that could replace laparoscopic techniques, that represents a potential threat.

Claims data also reveals seasonal patterns in procedure volumes. Many elective procedures show predictable seasonal variation, with volumes dipping during summer and holiday periods and peaking in Q1 and Q4. Understanding these patterns helps marketing teams time campaigns for maximum impact and helps sales teams set realistic quarterly targets.

For a comprehensive view of how data-driven approaches connect to broader medical device marketing strategy, see our medical device marketing guide.

Geographic Market Analysis

Claims data enables geographic analysis at multiple levels of granularity. National-level analysis reveals overall market size and trends. State-level analysis shows regional variation in procedure adoption, which may reflect differences in clinical practice patterns, payer mix, or regulatory environment. MSA-level (Metropolitan Statistical Area) analysis identifies specific metropolitan markets where procedure volumes are highest or growing fastest. ZIP code-level analysis supports territory planning and targeting at the most granular level.

Geographic analysis often reveals surprising patterns. A procedure that is standard of care in one region may be underutilized in another, representing an untapped market. Conversely, a region with already-high adoption may be saturated, making it a less attractive target for new customer acquisition. Claims data provides the evidence to make these distinctions objectively rather than relying on sales team anecdotes.

Competitive Intelligence

While claims data does not typically identify specific device brands (with the notable exception of implant-specific procedure codes and HCPCS codes for some categories), it does reveal competitive dynamics. By analyzing procedure volumes by facility and comparing them to your sales data, you can identify hospitals where your devices are underrepresented relative to their procedure volume, which signals competitive displacement or a greenfield opportunity.

For device categories where specific HCPCS or ICD-10-PCS codes exist, claims data can provide direct market share estimates. Orthopedic implants, cardiac devices, and some surgical robots have procedure codes specific enough to infer device usage patterns. Even for categories without device-specific codes, claims data combined with sales data enables share-of-procedure analysis that quantifies your penetration at the facility level.

Using Claims Data for Sales Targeting

Physician-Level Targeting

Claims data enables precise physician-level targeting by revealing which physicians perform the procedures your devices support, how frequently they perform them, and where. A surgeon who performs 200 spine procedures per year at a major academic medical center is a very different target than one who performs 20 per year at a community hospital. Claims data quantifies this difference and allows sales teams to prioritize high-volume targets.

Beyond volume, claims data reveals procedural mix. A surgeon who performs a high proportion of complex cases may be a better candidate for advanced instrumentation than one whose cases are predominantly routine. Payer mix data shows whether a surgeon's patients are primarily commercially insured (higher reimbursement) or Medicare/Medicaid (lower reimbursement), which affects the economic case for adopting a new device.

Our medical device marketing services include claims data analysis and physician targeting as core components of our data-driven marketing approach for device manufacturers.

Facility-Level Targeting

Claims data supports facility-level targeting by showing procedure volumes, case complexity, and payer mix at the hospital level. This data helps sales teams identify high-value target accounts and prioritize their outreach. A hospital that performs 1,000 total joint replacements per year represents significantly more revenue potential than one that performs 100, but the competitive landscape and buying process may differ significantly as well.

Facility-level claims data also reveals trends. A hospital with rapidly growing procedure volumes in your category may be expanding its surgical program and actively investing in new equipment. A hospital with declining volumes may be consolidating services or losing surgeons to competitors. These trend signals help sales teams focus on facilities where timing favors a successful engagement.

Referral Pattern Analysis

Claims data can reveal referral patterns between primary care physicians and specialists, and between community hospitals and tertiary care centers. Understanding these patterns helps device companies identify the referring physicians who drive patient volume to their key surgeon customers. Marketing programs that engage referring physicians can increase case volumes for surgeons who already use your devices, creating a pull-through effect that benefits both the surgeon and the device manufacturer.

Referral analysis is particularly valuable for complex procedures that require a multidisciplinary care pathway. For example, a patient receiving a spinal cord stimulator typically passes through primary care, pain management, neurology, and neurosurgery before reaching the implanting physician. Claims data maps this entire pathway, identifying every provider who influences the treatment decision and the eventual device selection.

Using Claims Data for Reimbursement Strategy

Understanding Reimbursement Landscapes

Claims data provides detailed information about how procedures are reimbursed across payers, geographies, and care settings. Average reimbursement rates, payment variation between payers, denial rates, and trends in coverage decisions all inform device marketing strategy. A device that is well-reimbursed under commercial insurance but poorly reimbursed under Medicare faces different marketing challenges than one with consistent reimbursement across payers.

For new devices seeking reimbursement, claims data from analogous procedures helps build the economic case. If you can demonstrate that your device reduces the number of procedures needed, decreases hospital readmissions, or shifts cases from inpatient to outpatient settings, claims data provides the evidence to support reimbursement applications and health economic arguments.

Site of Service Shifts

One of the most significant trends in healthcare is the shift of procedures from hospital inpatient settings to hospital outpatient departments (HOPDs) and ambulatory surgery centers (ASCs). Claims data tracks this shift in real time, showing which procedures are migrating to lower-cost settings and how quickly the transition is occurring. For medical device companies, site-of-service shifts create both opportunities and challenges. ASCs may prefer different device configurations, may be more price-sensitive, and may have different purchasing processes than hospital systems.

Claims data allows device companies to quantify the ASC opportunity for their specific procedures and to identify the ASCs with the highest relevant procedure volumes. This intelligence supports marketing programs targeted specifically at the ASC segment, which requires different messaging and value propositions than hospital marketing.

Data Quality Considerations and Limitations

Known Limitations of Claims Data

Claims data is powerful, but it has important limitations that marketers must understand. First, claims data reflects billing, not clinical reality. Procedures may be coded differently than they were performed for billing optimization purposes. Upcoding, unbundling, and other coding practices introduce noise into the data.

Second, claims data has a lag. Commercial claims databases typically reflect data that is three to six months old by the time it is available for analysis. Medicare data can be six to twelve months old. This lag means that claims data is better suited for strategic analysis and trend identification than for real-time tactical decisions.

Third, claims data does not capture uninsured patients or procedures paid out of pocket, which represents a meaningful share of certain procedure categories, particularly cosmetic and elective procedures. Fourth, claims data coverage varies by payer and geography. A database that covers 60% of commercially insured lives may have excellent coverage in some states and poor coverage in others.

Fifth, privacy regulations restrict how claims data can be used. HIPAA's minimum necessary standard requires that data be de-identified or that the user have a valid reason for accessing identified data. Most commercial claims databases provide de-identified data that cannot be traced to individual patients, though provider-level data (aggregated by NPI) is generally available and extremely useful for marketing purposes.

Ensuring Compliance

Using claims data for marketing requires compliance with HIPAA, state privacy laws, and the terms of use established by data vendors. While medical device manufacturers are generally not covered entities under HIPAA, the data vendors they work with are, and vendor contracts include provisions about acceptable data use. Marketing applications are generally permissible when using de-identified or aggregated data, but using patient-level identified data for marketing purposes would violate HIPAA.

State laws may impose additional restrictions. Some states restrict the use of claims data from their all-payer databases to specific research and policy applications, excluding commercial marketing use. Understanding these restrictions before building marketing programs on claims data is essential to avoiding legal issues.

Building a Claims Data Strategy

Starting with Free Public Data

Medical device companies that are new to claims data analysis should start with freely available public datasets. CMS Medicare data provides a solid foundation for understanding procedure volumes, provider activity, and geographic patterns. While Medicare only covers a portion of the population, it represents a large share of many device-relevant procedure categories, particularly in orthopedics, cardiac, and vascular specialties where patients tend to be older.

The Medicare Provider Utilization and Payment data files can be downloaded from data.cms.gov and analyzed using standard tools like Excel, Tableau, or Python. These files reveal procedure volumes and payment amounts for every Medicare-participating physician in the country, providing immediate value for sales targeting and market sizing at zero cost.

Layering Commercial Data

As your claims data capabilities mature, layer commercial claims databases on top of public data to fill coverage gaps. Commercial data is particularly valuable for procedure categories that skew toward younger populations, for geographic areas where Medicare penetration is low, and for specialties where commercial insurance represents the majority of payer mix.

Start with a focused data purchase rather than a comprehensive database license. Many vendors will sell data for specific procedure codes, specific geographies, or specific time periods at a fraction of the cost of a full database license. This targeted approach lets you prove the value of claims data before committing to a larger investment.

Integrating Claims Data with Internal Data

The greatest value from claims data comes when it is integrated with your internal data. Overlaying claims-based procedure volumes on your sales data reveals your market share at the facility and geographic level. Combining physician procedure data with your CRM contact records identifies high-volume surgeons who are not yet in your sales pipeline. Merging claims-based referral patterns with your customer data identifies the referring physicians who drive volume to your key accounts.

This integration requires a data infrastructure that can handle both external claims datasets and internal sales and marketing data. A customer data platform (CDP), data warehouse, or business intelligence tool provides the analytical environment needed to combine these data sources and extract actionable insights.

Our healthcare SEO services complement claims data strategies by ensuring that the physicians and facilities you identify through data analysis can find your content and resources through organic search.

Practical Applications and Case Examples

To illustrate the practical value of claims data, consider several scenarios drawn from our work with medical device clients. A spine device manufacturer used Medicare procedure data to identify the top 100 spine surgery centers by volume in the southeastern United States. Cross-referencing this list with their CRM revealed that they had no active sales relationship with 35 of these facilities, representing significant untapped market opportunity. A targeted outreach campaign to these facilities generated 12 new product evaluations within six months.

An orthopedic implant company analyzed claims data to track the shift of total joint replacements from inpatient to outpatient settings in their key markets. They found that ASC-based joint replacements had grown 40% year over year while hospital inpatient volumes were flat. This data drove a strategic decision to develop ASC-specific product configurations and marketing materials, positioning the company ahead of competitors who had not yet recognized the shift.

A cardiac device manufacturer used referral pattern analysis to identify the cardiologists who referred the most patients to their implanting electrophysiologists. They developed a referral education program targeting these cardiologists with clinical evidence about the benefits of their device, resulting in a measurable increase in referral volumes to their key implanting physicians.

These examples illustrate a common theme: claims data does not replace marketing creativity or sales skill. It sharpens them. By providing an objective, evidence-based foundation for targeting, messaging, and resource allocation, claims data helps medical device companies focus their efforts where the opportunity is greatest and the probability of success is highest.

The medical device companies that treat claims data as a strategic asset rather than a one-time research project will build a lasting competitive advantage. The data is available, the analytical tools are accessible, and the potential impact on marketing effectiveness and sales productivity is substantial. Whether you start with free Medicare data or invest in a comprehensive commercial database, the key is to begin, to learn, and to let data-driven insights compound over time into a marketing operation that consistently outperforms competitors who rely on intuition alone.